Why would Labcon take stock to write it off? Doesn't make sense....

Why would Labcon take stock to write it off? Doesn't make sense.

Regardless of how you read the announcement, the positive is that Labcon seem to be interested in selling it again, and if they get $1.3m on tick but use it to make a sale then its still a huge positive. Remember these things are not one-off purchases, end users require more vials as they go so they are multi-year agreements - repeat customers. If BCT are indeed giving them a credit, it certainly incentivises Labcon to get out there and sell it to their network.

I assume there will be more commentary around this come the end of the quarter.